PAG
CNTX icon

Private Advisor Group’s Context Therapeutics CNTX Stock Holding History

Private Advisor Group’s Portfolio CNTX Stock Details CNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.7K Buy
+125,852
New +$255K ﹤0.01% 2457

Other funds holding CNTX

New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
SFG
Strive Financial Group Carmel, Indiana $231M AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Private Advisor Group's CNTX Position: Q2 2026 in Review

Private Advisor Group opened a new position in Context Therapeutics (CNTX) in Q2 2026: 125,852 shares worth $69.7K. The stake represents ﹤0.01% of the portfolio and ranks #2457 among its holdings.

8 funds tracked by Wall St. Rank hold CNTX as of Q2 2026.

  • Private Advisor Group held 125,852 shares of Context Therapeutics worth $69.7K as of Q2 2026.
  • Context Therapeutics was a new Private Advisor Group position in Q2 2026.
  • Context Therapeutics made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #2457 holding.
  • 8 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.